Resveratrol inhibits phenotypic switching of neointimal vascular smooth muscle cells after balloon injury through blockade of notch pathway

Journal of Cardiovascular Pharmacology

Volumn 63, Issue 3, 2014, Pages 233-239

  Zhang, Jing ^a   Chen, Jing ^a   Xu, Changwu ^a   Yang, Jian ^b   Guo, Qing ^b   Hu, Qi ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Neointimal hyperplasia; Notch; Phenotypic switching; Resveratrol; Vascular smooth muscle cell

Indexed keywords

ALPHA ACTIN; COLLAGEN; CYCLINE; HEY 1 PROTEIN; HEY 2 PROTEIN; JAGGED1; MYOSIN HEAVY CHAIN; N [N (3, 5 DIFLUOROPHENACETYL)ALANYL]PHENYLGLYCINE T BUTYL ESTER; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PHENYLGLYCINE; RESVERATROL; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CAROTID ARTERY INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HYPERPLASIA; MALE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SPRAGUE DAWLEY RAT; STARVATION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HYPERPLASIA; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH1; STILBENES; TIME FACTORS;

EID: 84896318815     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000040     Document Type: Article

References (37)

1. Zargham R. Preventing restenosis after angioplasty: A multistage approach. Clin Sci (Lond). 2008;114:257-264
2. Xie C, Ritchie RP, Huang H, et al. Smooth muscle cell differentiation in vitro: Models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol. 2011;31:1485-1494
3. Landzberg BR, Frishman WH, Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis. 1997;39:361-398
4. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801
5. Han Y, Deng J, Guo L, et al. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc Res. 2008;78:597-604
6. Zhu G, Chen H, Zhang W. Phenotype switch of vascular smooth muscle cells after siRNA silencing of filamin. Cell Biochem Biophys. 2011;61: 47-52
7. Song M, Yu X, Cui X, et al. Blockade of connexin 43 hemichannels reduces neointima formation after vascular injury by inhibiting proliferation and phenotypic modulation of smooth muscle cells. Exp Biol Med( Maywood). 2009;234:1192-1200
8. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011;1215:22-33
9. Breen DM, Dolinsky VW, Zhang H, et al. Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase- dependent mechanism. Atherosclerosis. 2012;222:375-381
10. Tokunou T, Shibata R, Kai H, et al. Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells. Circulation. 2003;108:1246-1252
11. Gescher AJ, Steward WP. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: A conundrum. Cancer Epidemiol Biomarkers Prev. 2003;12:953-957
12. Schreiner CE, Kumerz M, Gesslbauer J, et al. Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. Cardiovasc Res. 2011;90:140-147
13. Natarajan R, Pei H, Gu JL, et al. Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury. Cardiovasc Res. 1999;41: 489-499
14. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517
15. Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990;70:1177-1209
16. Boccardi C, Cecchettini A, Caselli A, et al. A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell Tissue Res. 2007;328:185-195
17. Bravo R, Somoza B, Ruiz-Gayo M, et al. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats. Hypertension. 2001;37:E4-E10
18. Hao H, Gabbiani G, Camenzind E, et al. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol. 2006;26:326-332
19. Thyberg J. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol. 1998;13:871-891
20. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res. 2005;96:280-291
21. Manabe I, Nagai R. Regulation of smooth muscle phenotype. Curr Atheroscler Rep. 2003;5:214-222
22. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 1999;190:105-118
23. Van Der Loop FT, Gabbiani G, Kohnen G, et al. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol. 1997;17:665-671
24. Bochaton-Piallat ML, Ropraz P, Gabbiani F, et al. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 1996;16:815-820
25. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61
26. Gordon D, Reidy MA, Benditt EP, et al. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 1990;87:4600-4604
27. Dong LH, Wen JK, Liu G, et al. Blockade of the Ras-extracellular signalregulated kinase 1/2 pathway is involved in smooth muscle 22 alphamediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia. Arterioscler Thromb Vasc Biol. 2010;30: 683-691
28. Jeon KI, Jono H, Miller CL, et al. Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells. FEBS J. 2010;277: 5026-5039
29. Kang H, Davis-Dusenbery BN, Nguyen PH, et al. Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem. 2012;287:3976-3986
30. Kiyan Y, Limbourg A, Kiyan R, et al. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arterioscler Thromb Vasc Biol. 2012;32:110-122
31. Komalavilas P, Shah PK, Jo H, et al. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem. 1999;274:34301-34309
32. Boucher J, Gridley T, Liaw L. Molecular pathways of notch signaling in vascular smooth muscle cells. Front Physiol. 2012;3:81
33. D'Souza B, Meloty-Kapella L, Weinmaster G. Canonical and non-canonical Notch ligands. Curr Top Dev Biol. 2010;92:73-129
34. Morrow D, Guha S, Sweeney C, et al. Notch and vascular smooth muscle cell phenotype. Circ Res. 2008;103:1370-1382
35. Lin H, Xiong W, Zhang X, et al. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep. 2011;26:925-930
36. Yu XM, Jaskula-Sztul R, Ahmed K, et al. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther. 2013; 12:1276-1287
37. Wang W, Prince CZ, Hu X, et al. HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochem Biophysical Res Commun. 2003;308:596-601